Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases

被引:49
作者
Chalabreysse, L
Etienne-Mastroianni, B
Adeleine, P
Cordier, JF
Greenland, T
Thivolet-Bejui, F
机构
[1] Hop Louis Pradel, Serv Anat & Cytol Pathol, Dept Pathol, F-69394 Lyon, France
[2] Hop Louis Pradel, Dept Pneumol, F-69394 Lyon, France
[3] Ctr Hosp Lyon Sud, Dept Biostat, Lyon, France
[4] Ctr Hosp Lyon Sud, UMR 754, Lyon, France
关键词
thymic carcinoma; neuroendocrine tumours; thymus; mediastinum; immunohistochemistry;
D O I
10.1111/j.1365-2559.2004.01796.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To study 19 cases of primary thymic carcinoma in order to define the clinicopathological features and the precise histochemical profile of this rare and heterogeneous group of tumours of the anterior mediastinum. Methods and results: The study group consisted of 13 males and six females, with a mean age of 58.5 years (range 29-75 years). Superior vena cava syndrome and chest pain were the main presenting symptoms. Three patients were asymptomatic. No patient had myasthenia gravis. Six different histological types were identified: neuroendocrine tumours (six patients), epidermoid carcinoma (five patients), sarcomatoid carcinoma (three patients), lymphoepithelioma-like carcinoma (two patients), mucoepidermoid carcinoma, clear cell carcinoma, and undifferentiated carcinoma (one patient each). The clear cell carcinoma was associated with a thymic cyst. No association with thymoma was observed. Surgical resection, performed in 10 cases, was complete in two. Sixteen patients received thoracic radiation, and 11 received systemic chemotherapy. Follow-up information was available in 16 cases; 12 patients presented with local or metastatic relapse, and 10 patients died of their tumour. The overall 5-year survival was 14.5%. Conclusion: Primary thymic carcinoma is a very heterogeneous group of tumours of the anterior mediastinum with an aggressive clinical behaviour, and a poor overall prognosis.
引用
收藏
页码:367 / 374
页数:8
相关论文
共 34 条
[1]   Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis - A retrospective study of 90 tumors [J].
Chalabreysse, L ;
Roy, P ;
Cordier, JF ;
Loire, R ;
Gamondes, JP ;
Thivolet-Bejui, F .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (12) :1605-1611
[2]  
CHAN JKC, 1995, AM J SURG PATHOL, V19, P1115
[3]   Detection of bcl-2 and p53 in thymoma: Expression of bcl-2 as a reliable marker of tumor aggressiveness [J].
Chen, FF ;
Yan, JJ ;
Jin, YT ;
Su, IJ .
HUMAN PATHOLOGY, 1996, 27 (10) :1089-1092
[4]   Thymic carcinoma - Analysis of nineteen clinicopathological studies [J].
Chung, DA .
THORACIC AND CARDIOVASCULAR SURGEON, 2000, 48 (02) :114-119
[5]   Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity [J].
Dorfman, DM ;
Shahsafaei, A ;
Chan, JKC .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (08) :936-940
[6]   Thymic sarcomatoid carcinoma with skeletal muscle differentiation: report of two cases, one with cytogenetic analysis [J].
Eimoto, T ;
Kitaoka, M ;
Ogawa, H ;
Niwa, H ;
Murase, T ;
Tateyama, H ;
Inagaki, H ;
Soji, T ;
Wang, HJ .
HISTOPATHOLOGY, 2002, 40 (01) :46-57
[7]   Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA (EBER) in situ hybridization [J].
Engel, PJH .
APMIS, 2000, 108 (06) :393-397
[8]   Neuroendocrine tumors of the thymus: A clinicopathological and prognostic study [J].
Gal, AA ;
Kornstein, MJ ;
Cohen, C ;
Duarte, IG ;
Miller, JI ;
Mansour, KA .
ANNALS OF THORACIC SURGERY, 2001, 72 (04) :1179-1182
[9]   CARCINOMA OF THE THYMUS WITH CLEAR-CELL FEATURES - REPORT OF 8 CASES AND REVIEW OF THE LITERATURE [J].
HASSERJIAN, RP ;
KLIMSTRA, DS ;
ROSAI, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (07) :835-841
[10]   High frequency of p53 protein expression in thymic carcinoma but not in thymoma [J].
Hino, N ;
Kondo, K ;
Miyoshi, T ;
Uyama, T ;
Monden, Y .
BRITISH JOURNAL OF CANCER, 1997, 76 (10) :1361-1366